4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-22-011836
Options or other derivatives
- General Counsel and Secretary acquired 49,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| KASINGER JAMES R. General Counsel and Secretary | 2022-02-18 | Grant or award · Stock Option (Right to Buy) | +34,200 | 34,200 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2022-02-18 | Grant or award · Restricted Stock Units | +15,300 | 15,300 | D | ||
Loading xslF345X03/doc4.xml…